Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $629.03M.
ENTERPRISE VALUE (EV)
$629.03M
OmniAb, Inc.
Market Cap
$654.55M
Enterprise Value (EV)
$629.03M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| OmniAb, Inc. (OABI) | $654.55M | $629.03M |
| Aura Biosciences, Inc. (AURA)vs › | $639.30M | $588.06M |
| ArriVent BioPharma, Inc. (AVBP)vs › | $659.73M | $505.40M |
| Prime Medicine, Inc. (PRME)vs › | $633.97M | $698.99M |
| Climb Bio, Inc. (CLYM)vs › | $633.90M | $591.11M |
| MiMedx Group, Inc. (MDXG)vs › | $669.77M | $535.43M |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $672.27M | $641.12M |
| Helus Pharma Inc. (HELP)vs › | $681.21M | $515.04M |
| Annexon, Inc. (ANNX)vs › | $681.58M | $506.97M |
| Anteris Technologies Global Corp. (AVR)vs › | $690.28M | $436.22M |
Market Cap
$654.55M
Total Debt
$0.00
Cash
$25.52M
Enterprise Value
$629.03M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
